Literature DB >> 30566978

Interstitial Cystitis/Bladder Pain Syndrome.

Ioana Marcu1, E Cristian Campian1, Frank F Tu2.   

Abstract

Interstitial cystitis/bladder pain syndrome is an uncommon but potentially devastating pelvic pain disorder affecting both women and men. This condition is often confusable and comorbid with other pelvic pain disorders. Although our understanding of the underlying pathophysiology is growing, the exact longitudinal course by which peripheral and central aberrations involving the bladder mucosa, peripheral inflammation, and central dysregulation of bladder sensitivity create painful bladder symptoms remains an area in need of further study. Only a limited number of drugs have been approved for treatment by the Food and Drug Administration, and overall durable efficacy of the many treatments reviewed in recent American Urological Association guidelines remains suboptimal, making awareness, early diagnosis, and use of effective treatments early in the disease course, where neural changes may still be reversible, imperative. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30566978     DOI: 10.1055/s-0038-1676089

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN: 1526-4564            Impact factor:   1.303


  10 in total

Review 1.  Age-Related Macular Degeneration Masquerade: A Review of Pentosan Polysulfate Maculopathy and Implications for Clinical Practice.

Authors:  Chirantan Mukhopadhyay; Timothy M Boyce; Karen M Gehrs; James C Folk; Robert F Mullins; Yi Luo; Karl Kreder; Elliott H Sohn
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2022 Mar-Apr 01

Review 2.  Preclinical models of endometriosis and interstitial cystitis/bladder pain syndrome: an Innovative Medicines Initiative-PainCare initiative to improve their value for translational research in pelvic pain.

Authors:  Paulina Nunez-Badinez; Bianca De Leo; Alexis Laux-Biehlmann; Anja Hoffmann; Thomas M Zollner; Philippa T K Saunders; Ioannis Simitsidellis; Ana Charrua; Francisco Cruz; Raul Gomez; Miguel Angel Tejada; Stephen B McMahon; Laure Lo Re; Florent Barthas; Katy Vincent; Judy Birch; Jane Meijlink; Lone Hummelshoj; Patrick J Sweeney; J Douglas Armstrong; Rolf-Detlef Treede; Jens Nagel
Journal:  Pain       Date:  2021-09-01       Impact factor: 6.961

Review 3.  P2 purinergic receptor dysregulation in urologic disease.

Authors:  Janielle P Maynard; Karen S Sfanos
Journal:  Purinergic Signal       Date:  2022-06-10       Impact factor: 3.950

4.  An indirect comparison meta-analysis of noninvasive intravesical instillation and intravesical injection of botulinum toxin-A in bladder disorders.

Authors:  Gao Yunfeng; Lai Fei; Liu Junbo; Yang Dingyuan; Huang Chaoyou
Journal:  Int Urol Nephrol       Date:  2022-01-19       Impact factor: 2.370

5.  B6 Mouse Strain: The Best Fit for LPS-Induced Interstitial Cystitis Model.

Authors:  Ching-Hao Chen; Chun-Hou Liao; Kuo-Chiang Chen; Kuan-Lin Wang; Xiao-Wen Tseng; Wei-Kung Tsai; Han-Sun Chiang; Yi-No Wu
Journal:  Int J Mol Sci       Date:  2021-11-08       Impact factor: 5.923

Review 6.  Bladder Microbiome in the Context of Urological Disorders-Is There a Biomarker Potential for Interstitial Cystitis?

Authors:  Thomas Bschleipfer; Isabell Karl
Journal:  Diagnostics (Basel)       Date:  2022-01-22

7.  Electro-Acupuncture for Bladder Pain Syndrome: A Protocol of a Randomized Controlled Trial and Study for Central Mechanism.

Authors:  Yunyun Xu; Yangyun Chen; Yan Shi; Jianhua Lu; Zonglin Wu; Zhe Liu; Yuerong Chen; Wenqin Ni; Qike Ding; Wei Dai; Xinyuan Wu; Jianqiao Fang; Yuanyuan Wu
Journal:  J Pain Res       Date:  2022-07-13       Impact factor: 2.832

Review 8.  Molecular Mechanisms and Key Processes in Interstitial, Hemorrhagic and Radiation Cystitis.

Authors:  Clément Brossard; Anne-Charlotte Lefranc; Anne-Laure Pouliet; Jean-Marc Simon; Marc Benderitter; Fabien Milliat; Alain Chapel
Journal:  Biology (Basel)       Date:  2022-06-28

9.  Multidisciplinary treatment for functional urological disorders with psychosomatic comorbidity in a tertiary pelvic care center-A retrospective cohort study.

Authors:  Vera van Knippenberg; Carsten Leue; Desiree Vrijens; Gommert van Koeveringe
Journal:  Neurourol Urodyn       Date:  2022-03-29       Impact factor: 2.367

10.  Pycnogenol® Supplementation Prevents Recurrent Urinary Tract Infections/Inflammation and Interstitial Cystitis.

Authors:  A Ledda; S Hu; M R Cesarone; G Belcaro; M Dugall; B Feragalli; R Cotellese; M Hosoi; E Ippolito; M Corsi; R Luzzi
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-23       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.